1. Home
  2. NEXT vs LQDA Comparison

NEXT vs LQDA Comparison

Compare NEXT & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEXT
  • LQDA
  • Stock Information
  • Founded
  • NEXT 2010
  • LQDA 2004
  • Country
  • NEXT United States
  • LQDA United States
  • Employees
  • NEXT N/A
  • LQDA N/A
  • Industry
  • NEXT Oil & Gas Production
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEXT Energy
  • LQDA Health Care
  • Exchange
  • NEXT Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • NEXT 1.8B
  • LQDA 1.9B
  • IPO Year
  • NEXT N/A
  • LQDA 2018
  • Fundamental
  • Price
  • NEXT $7.44
  • LQDA $24.22
  • Analyst Decision
  • NEXT Hold
  • LQDA Strong Buy
  • Analyst Count
  • NEXT 2
  • LQDA 9
  • Target Price
  • NEXT $9.00
  • LQDA $32.67
  • AVG Volume (30 Days)
  • NEXT 6.2M
  • LQDA 2.9M
  • Earning Date
  • NEXT 11-06-2025
  • LQDA 11-12-2025
  • Dividend Yield
  • NEXT N/A
  • LQDA N/A
  • EPS Growth
  • NEXT N/A
  • LQDA N/A
  • EPS
  • NEXT N/A
  • LQDA N/A
  • Revenue
  • NEXT N/A
  • LQDA $19,322,000.00
  • Revenue This Year
  • NEXT N/A
  • LQDA $405.58
  • Revenue Next Year
  • NEXT N/A
  • LQDA $373.93
  • P/E Ratio
  • NEXT N/A
  • LQDA N/A
  • Revenue Growth
  • NEXT N/A
  • LQDA 30.20
  • 52 Week Low
  • NEXT $4.94
  • LQDA $9.71
  • 52 Week High
  • NEXT $12.12
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • NEXT 43.44
  • LQDA 51.93
  • Support Level
  • NEXT $6.45
  • LQDA $21.35
  • Resistance Level
  • NEXT $7.39
  • LQDA $23.33
  • Average True Range (ATR)
  • NEXT 0.37
  • LQDA 1.19
  • MACD
  • NEXT 0.13
  • LQDA -0.07
  • Stochastic Oscillator
  • NEXT 97.02
  • LQDA 69.54

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: